With the uptick in merger and acquisition activity, whether it be for tax-inversion or strategic reasons, investors should focus on the target company, which can benefit from the deal immediately.
Moat-building cost and brand advantages position the firm well.
As credit spreads have tightened on a nearly continuous trend over the past year, they are becoming richly valued relative to their historical average.
Industry dynamics are shifting in the wake of Zimmer's Biomet acquisition.
©2014 Morningstar Advisor. All right reserved.